What Researchers Did
Researchers conducted a literature review to assess the evidence for hyperbaric oxygen therapy (HBO2) in treating autism spectrum disorders (ASD).
What They Found
The review found weak evidence for hyperbaric oxygen therapy in autism spectrum disorders. Only one randomized controlled study suggested a treatment benefit, but it was considered likely flawed.
What This Means for Canadian Patients
Based on current evidence, Canadian patients with autism spectrum disorders should not pursue hyperbaric oxygen therapy. It is not recommended until robust, well-designed studies demonstrate clear benefits and long-term outcomes.
Canadian Relevance
This study has no direct Canadian connection as it is a literature review without specific geographic focus.
Study Limitations
The primary limitation of this review is the scarcity of high-quality evidence on hyperbaric oxygen therapy for autism spectrum disorders.